These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26629881)

  • 1. Initial Surgery and Survival in Stage IV Breast Cancer in the United States, 1988-2011.
    Thomas A; Khan SA; Chrischilles EA; Schroeder MC
    JAMA Surg; 2016 May; 151(5):424-31. PubMed ID: 26629881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
    Tan Y; Li X; Chen H; Hu Y; Jiang M; Fu J; Yuan Y; Ding K
    Oncotarget; 2016 Oct; 7(43):70991-71000. PubMed ID: 27542240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
    Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
    BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished survival in patients with inner versus outer quadrant breast cancers.
    Gaffney DK; Tsodikov A; Wiggins CL
    J Clin Oncol; 2003 Feb; 21(3):467-72. PubMed ID: 12560437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
    Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer.
    Shen X; Anne PR; Keith SW; Wojcieszynski A; Mishra MV; Bar-Ad V; Showalter TN
    Am J Clin Oncol; 2014 Jun; 37(3):241-7. PubMed ID: 23241502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.
    Gnerlich J; Jeffe DB; Deshpande AD; Beers C; Zander C; Margenthaler JA
    Ann Surg Oncol; 2007 Aug; 14(8):2187-94. PubMed ID: 17522944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis.
    Lane WO; Thomas SM; Blitzblau RC; Plichta JK; Rosenberger LH; Fayanju OM; Hyslop T; Hwang ES; Greenup RA
    Ann Surg; 2019 Mar; 269(3):537-544. PubMed ID: 29227346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis.
    Gao JJ; Cheng J; Bloomquist E; Sanchez J; Wedam SB; Singh H; Amiri-Kordestani L; Ibrahim A; Sridhara R; Goldberg KB; Theoret MR; Kluetz PG; Blumenthal GM; Pazdur R; Beaver JA; Prowell TM
    Lancet Oncol; 2020 Feb; 21(2):250-260. PubMed ID: 31859246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and tumor characteristics associated with primary tumor resection in women with Stage IV breast cancer: analysis of 1988-2003 SEER data.
    Gnerlich J; Dueker JM; Jeffe DB; Deshpande AD; Thompson S; Margenthaler JA
    Breast J; 2008; 14(6):538-42. PubMed ID: 19000055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
    Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
    Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Primary Tumor Surgery in Stage IV Male Breast Cancer.
    Muzaffar M; Kachare S; Vohra N
    Clin Breast Cancer; 2017 Jun; 17(3):e143-e149. PubMed ID: 27998656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
    Kim HJ; Kang E; Kim JH; Kim SH; Kim YJ; Kim IA; Eom KY; Chae SM; Kang KM; Kim EK; Kim SW
    Clin Breast Cancer; 2018 Oct; 18(5):e1037-e1044. PubMed ID: 29909259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
    Gu Y; Wu G; Zou X; Huang P; Yi L
    Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.